Results 41 to 50 of about 1,370,088 (427)

Altered cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy.

open access: yesmedRxiv, 2021
SARS-CoV-2 mRNA vaccination in healthy individuals generates effective immune protection against COVID-19. Little is known, however, about the SARS-CoV-2 mRNA vaccine-induced responses in immunosuppressed patients.
Sokratis A. Apostolidis   +27 more
semanticscholar   +1 more source

Influence of the COVID-19 pandemic and social media on the behaviour of pregnant and lactating women towards vaccination: a scoping review

open access: yesBMJ Open, 2023
Background Pregnant women, foetuses and infants are at risk of infectious disease-related complications. Maternal vaccination is a strategy developed to better protect pregnant women and their offspring against infectious disease-related morbidity and ...
Pierre Van Damme   +5 more
doaj   +1 more source

Maternal education, empowerment, economic status and child polio vaccination uptake in Pakistan: a population based cross sectional study [PDF]

open access: yes, 2017
Objectives: To explore the association of maternal education and empowerment with childhood polio vaccination using nationally representative data of Pakistani mothers in a reproductive age group. Design: Cross-sectional.
Khan, Muhammad Tahir   +2 more
core   +1 more source

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2020

open access: yesMMWR. Morbidity and mortality weekly report, 2021
The Advisory Committee on Immunization Practices (ACIP) recommends that adolescents aged 11-12 years routinely receive tetanus, diphtheria, and acellular pertussis (Tdap); meningococcal conjugate (MenACWY); and human papillomavirus (HPV) vaccines.
C. Pingali   +8 more
semanticscholar   +1 more source

Effect of Vaccination on Household Transmission of SARS-CoV-2 in England

open access: yesNew England Journal of Medicine, 2021
Vaccination against SARS-CoV-2 with either ChAdOx1 nCoV-19, produced by AstraZeneca, or BNT162b2, produced by Pfizer, has been shown to produce a robust antibody response (1,2), and is effective in both preventing cases and reducing the severity of COVID-
Ross J. Harris   +5 more
semanticscholar   +1 more source

Dramatic decline of serogrup C meningococcal disease incidence in Catalonia (Spain) 24 months after a mass vaccination programme of children and young people [PDF]

open access: yes, 2001
STUDY OBJECTIVES The objective of this study was to evaluate the effectiveness of a mass vaccination programme carried out in Catalonia (Spain) in the last quarter of 1997 in response to an upsurge of serogroup C meningococcal disease (SCMD).
Domínguez García, Àngela   +4 more
core   +2 more sources

Vaccine Hesitancy, Acceptance, and Anti-Vaccination: Trends and Future Prospects for Public Health.

open access: yesAnnual Review of Public Health, 2021
An often-stated public health comment is that "vaccination is a victim of its own success." While the scientific and medical consensus on the benefits of vaccination is clear and unambiguous, an increasing number of people are perceiving vaccines as ...
È. Dubé   +3 more
semanticscholar   +1 more source

As Vacinas Salvam Vidas? Sim, Salvam!

open access: yesActa Médica Portuguesa, 2014
Desde a sua introdução e aplicação universal, as vacinas têm sido utilizadas com sucesso reduzindo a morbilidade e mortalidade das doenças às quais se destinam, ao nível individual e através da imunidade de rebanho (imunidade colectiva).
Tinne Lernout   +3 more
doaj   +1 more source

TIV vaccination modulates host responses to influenza virus infection that correlate with protection against bacterial superinfection [PDF]

open access: yes, 2019
Background: Influenza virus infection predisposes to secondary bacterial pneumonia. Currently licensed influenza vaccines aim at the induction of neutralizing antibodies and are less effective if the induction of neutralizing antibodies is low and/or the
Choi, Angela   +4 more
core   +2 more sources

Varicella: to vaccinate or not to vaccinate? [PDF]

open access: yesArchives of Disease in Childhood, 1998
Editor,—I am in complete agreement with Dr Aebi that strategies for delivering varicella vaccine effectively are critical to the success of immunisation programmes.1 In the USA great efforts are being made in this direction. Nevertheless, despite the licensure of varicella vaccine for routine use in the United …
openaire   +5 more sources

Home - About - Disclaimer - Privacy